Drug discovery company using AI and synthetic biology.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Absci Corporation in the last 30 days yet.
The 1 sources with the most insights about Absci Corporation on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Described as a high-risk, high-reward investment that is either a '100X or it's zero.' Quarterly earnings numbers are considered 'largely irrelevant' compared to progress on its drug development platform.
Described as a high-risk, high-reward investment that is either a '100X or it's zero.' Quarterly earnings numbers are considered 'largely irrelevant' compared to progress on its drug development platform.
Other assets that creators frequently mention in the same content as Absci Corporation.
The most active sources covering Absci Corporation (ABCL) on Kazuha are @amitinvesting. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Absci Corporation (ABCL) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Absci Corporation (ABCL) most frequently also discuss AMD, PINS, RKLB, TTD, TWLO. See the "Discussed alongside" section above for full asset pages.